Healio Minute Podcast, Neurology Edition: Top Headlines - Week of August 8, 2022
Click Here to Manage Email Alerts
In this edition, physicians should question patients with restless leg syndrome about cannabis use ; digital therapeutic improves symptoms of insomnia, anxiety and depression; more efficient sleep may benefit patients with fibromyalgia and insomnia and more.
Read the full coverage here:
Physicians should question patients with restless leg syndrome about cannabis use
Digital therapeutic improves symptoms of insomnia, anxiety, depression for 6 months
More efficient sleep may benefit patients with fibromyalgia, insomnia
FDA accepts new drug application, grants priority review for ALS treatment
Quanterix announces validation of biomarker detection test to aid in diagnosis of AD
References:
Kachechian T, et al. Prevalence of cannabis use in patients with restless leg syndrome for symptomatic relief. Presented at: SLEEP; June 5-8, 2022; Charlotte, N.C.
Nair N, et al. Effect of sleep on the relationship between pain-related disability and neural correlates of pain processing in adults with fibromyalgia and insomnia. Presented at: SLEEP; June 5-8, 2022; Charlotte, N.C.
Collapse
Read more about
Click Here to Manage Email Alerts
